Werbung
Werbung
TRAW
Traws Pharma, Inc. Common Stock
1.34
USDGesponsert
-0.06
-4.61%
09. Jan., 15:58 UTC -5
Geschlossen
Nach-Markt
1.35
+0.01
+0.67%
TRAW Ergebnisberichte
Positives Überraschungsverhältnis
TRAW übertreffen die 24 der letzten 34Schätzungen.
71%
Nächster Bericht
Datum des nächsten Berichts
30. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$1.94
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/--
Implizierte Änderung von Q4 24 (Revenue/ EPS)
-100.00%
/-102.03%
Traws Pharma, Inc. Common Stock earnings per share and revenue
On 13. Nov. 2025, TRAW reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -9.34 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 61.20 tausend, with a --% difference.
Looking ahead to Q4 25, 3 analysts forecast an EPS of -1.94 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Traws Pharma, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Traws Pharma, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Traws Pharma, Inc. Common Stock's Q3 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Traws Pharma, Inc. Common Stock expected to report next?
The next earning report is scheduled for 30. März 2026.
What are the forecasts for Traws Pharma, Inc. Common Stock's next earnings report?
Based on 3
analysts, Traws Pharma, Inc. Common Stock is expected to report EPS of -$1.94 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung